Abstract
Amphotericin B and N-D-ornithyl amphotericin B methyl ester were compared for therapeutic efficacies against experimentally induced cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis in rabbits. Antifungal activity of the two polyenes in vitro was similar for the yeasts used in these experiments. N-D-ornithyl amphotericin B methyl ester gave a slightly higher concentration in serum than amphotericin B did, but both drugs had similar elimination curves, and penetration into the cerebrospinal fluid was poor for both. Despite these similarities between the two polyenes, amphotericin B was much more effective than N-D-ornithyl amphotericin B methyl ester in the treatment of cryptococcal meningitis in rabbits. For C. albicans endocarditis, both polyenes had similar cure rates, but in vitro measurement of fungicidal activity in serum did not predict treatment outcome. For C. albicans pyelonephritis, both polyenes showed efficacy; because higher doses of the less toxic methyl ester could be used, it sterilized the urinary tract more often than amphotericin B. These studies indicate that in vivo and in vitro experiments may be needed to predict the results of treatment with polyenes.
MeSH Terms
Amphotericin B/analogs & derivatives,blood,cerebrospinal fluid,therapeutic use
Animals
Antifungal Agents/blood,cerebrospinal fluid,therapeutic use
Candidiasis/drug therapy
Cryptococcosis/drug therapy
Endocarditis/drug therapy,microbiology
Kinetics
Meningitis/drug therapy,microbiology
Microbial Sensitivity Tests
Mycoses/drug therapy,microbiology
Pyelonephritis/drug therapy,microbiology
Rabbits
Yeasts/drug effects
Chemicals
Antifungal Agents
ornithylamphotericin methyl ester
Amphotericin B
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Perfect J R
Durack D T
References (26)
26 references, click to expand
-
Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis.
Antimicrob Agents Chemother. 1985 Mar;27(3):363-6
PMID: 3994350
-
In vitro and in vivo comparisons of amphotericin B and N-D-ornithyl amphotericin B methyl ester.
Antimicrob Agents Chemother. 1985 Mar;27(3):302-5
PMID: 3994345
-
Simplified, accurate method for antibiotic assay of clinical specimens.
Appl Microbiol. 1966 Mar;14(2):170-7
PMID: 4959982
-
A pharmacologic guide to the clinical use of amphotericin B.
J Infect Dis. 1969 Oct;120(4):427-36
PMID: 5394441
-
Comparative in vitro antifungal activity of amphotericin B and amphotericin B methyl ester.
Antimicrob Agents Chemother. 1975 Jan;7(1):58-63
PMID: 1137359
-
Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester.
Antimicrob Agents Chemother. 1975 Jun;7(6):724-9
PMID: 1155916
-
Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity.
J Infect Dis. 1976 Feb;133(2):168-74
PMID: 1245764
-
Comparative toxicological studies of amphotericin B methyl ester and amphotericin B in mice, rats, and dogs.
Antimicrob Agents Chemother. 1976 Oct;10(4):687-90
PMID: 984803
-
Amphotericin B and amphotericin B methyl ester ascorbate. I. Chemotherapeutic activity against Candida albicans, Cryptococcus neoformans, and Blastomyces dermatitidis in mice.
J Infect Dis. 1976 Nov;134(5):423-7
PMID: 792355
-
Experimental Candida albicans endocarditis: characterization of the disease and response to therapy.
Infect Immun. 1977 Jul;17(1):140-7
PMID: 328393
-
New antifungal drugs in the therapy of systemic mycoses.
Scand J Infect Dis Suppl. 1978;(16):74-9
PMID: 373081
-
Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta.
J Antimicrob Chemother. 1980 Mar;6(2):241-9
PMID: 6769895
-
Chronic cryptococcal meningitis: a new experimental model in rabbits.
Am J Pathol. 1980 Oct;101(1):177-94
PMID: 7004196
-
Comparative in vitro susceptibility of yeasts to amphotericin B and three methyl ester derivatives.
Antimicrob Agents Chemother. 1981 Jan;19(1):106-9
PMID: 7247350
-
Effect of antibiotics on the immune response.
Am J Med. 1982 May;72(5):711-6
PMID: 7044118
-
Leukoencephalopathy in patients treated with amphotericin B methyl ester.
J Infect Dis. 1982 Aug;146(2):125-37
PMID: 7108268
-
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
J Infect Dis. 1982 Sep;146(3):429-35
PMID: 6286799
-
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study.
Ann Intern Med. 1983 Jan;98(1):13-20
PMID: 6293361
-
Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model.
J Infect Dis. 1983 Jun;147(6):1070-7
PMID: 6343524
-
Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191.
Am Rev Respir Dis. 1984 Feb;129(2):292-5
PMID: 6364905
-
Azole resistance in Candida albicans.
Sabouraudia. 1984;22(1):53-63
PMID: 6322363
-
High-pressure liquid chromatographic method for determination of Sch 28191 in biological fluids.
Antimicrob Agents Chemother. 1984 Jan;25(1):45-8
PMID: 6703683
-
Principles in the treatment of bacterial meningitis.
Am J Med. 1984 May 15;76(5A):224-30
PMID: 6372474
-
Ornithyl amphotericin methyl ester treatment of experimental candidiasis in rats.
Antimicrob Agents Chemother. 1984 Jul;26(1):108-9
PMID: 6476814
-
Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeys.
Antimicrob Agents Chemother. 1984 Oct;26(4):446-9
PMID: 6517539
-
Immunoadjuvant activity of amphotericin B as displayed in mice infected with Candida albicans.
Antimicrob Agents Chemother. 1985 Apr;27(4):625-31
PMID: 3890731